| Intrinsic Valuation of: DRREDDY | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 68 | Market Cap | ₹1,063B | |||||
| 2021 | - | - (-) | P/E Ratio | 19 | Total Asset | ₹493B | |||||
| 2022 | ₹9B | - (-) | Net Income | ₹57B | Total Debt | ₹4B | |||||
| 2023 | ₹40B | 341.6% (285.1%) | EBITDA | ₹97B | Total Liab | ₹156B | |||||
| 2024 | ₹18B | -55.0% (-60.4%) | Opr Margin | 0.22 | Debt/Equity | 0.01 | |||||
| 2025 | ₹12B | -33.2% (-42.7%) | PreTax Margin | 21.25 | BV/Share | 270 | |||||
| 5Y Average FCF | ₹20B | 84.5% (60.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | ₹15B | MBG Intrinsic Value | ₹606 | ||||||||
| 2027 | ₹19B | ||||||||||
| 2028 | ₹23B | ||||||||||
| 2029 | ₹29B | ||||||||||
| 2030 | ₹37B | ||||||||||
| 2031 | ₹46B | ||||||||||
| Terminal Value | ₹954B | Net Worth/Share | ₹405 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹747B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹15B | ₹911 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹4B | WACC | 7.3% | 794 | 856 | 932 | 1,024 | 1,141 | |||
| Equity Value | ₹758B | 7.4% | 787 | 848 | 921 | 1,012 | 1,125 | ||||
| Shares Outstanding | 832,129,984 | 7.4% | 779 | 839 | 911 | 1,000 | 1,110 | ||||
| 7.9% | 713 | 763 | 821 | 892 | 978 | ||||||
| DCF Intrinsic Value | ₹911 | 8.4% | 657 | 698 | 747 | 804 | 872 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||